NCT02692040View on ClinicalTrials.gov

Study of the Gut Hormone Analogue G3215 in Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Diabetes MellitusObesity
Interventions
DRUG

G3215

Gut hormone analogue

DRUG

Placebo

0.9% saline

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit, Leeds

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Covance

INDUSTRY

lead

Imperial College London

OTHER